These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 25769071

  • 1. Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies.
    Kubal C, Mangus R, Saxena R, Lobashevsky A, Higgins N, Fridell J, Tector AJ.
    Transplantation; 2015 Aug; 99(8):e49-56. PubMed ID: 25769071
    [Abstract] [Full Text] [Related]

  • 2. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
    Cheng EY, Kaneku H, Farmer DG.
    Clin Transpl; 2014 Aug; ():153-9. PubMed ID: 26281140
    [Abstract] [Full Text] [Related]

  • 3. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.
    Transplantation; 2013 Jan 27; 95(2):341-6. PubMed ID: 23197178
    [Abstract] [Full Text] [Related]

  • 4. De novo donor specific antibodies and patient outcomes in renal transplantation.
    DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA.
    Clin Transpl; 2011 Jan 27; ():351-8. PubMed ID: 22755430
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients.
    Cheng EY, Everly MJ, Kaneku H, Banuelos N, Wozniak LJ, Venick RS, Marcus EA, McDiarmid SV, Busuttil RW, Terasaki PI, Farmer DG.
    Transplantation; 2017 Apr 27; 101(4):873-882. PubMed ID: 27490417
    [Abstract] [Full Text] [Related]

  • 6. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing.
    Süsal C, Wettstein D, Döhler B, Morath C, Ruhenstroth A, Scherer S, Tran TH, Gombos P, Schemmer P, Wagner E, Fehr T, Živčić-Ćosić S, Balen S, Weimer R, Slavcev A, Bösmüller C, Norman DJ, Zeier M, Opelz G, Collaborative Transplant Study Report.
    Transplantation; 2015 Sep 27; 99(9):1976-80. PubMed ID: 25769065
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts.
    Cooper JE, Gralla J, Chan L, Wiseman AC.
    Clin Transpl; 2011 Sep 27; ():359-64. PubMed ID: 22755431
    [Abstract] [Full Text] [Related]

  • 8. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J, Xue W, Qing X, Jing X, Hou J, Tian X, Guo Q, He X, Cai J.
    Clin Transpl; 2014 Sep 27; ():223-30. PubMed ID: 26281149
    [Abstract] [Full Text] [Related]

  • 9. Evolution of donor-specific antibodies (DSA) and incidence of de novo DSA in solid organ transplant recipients after switch to everolimus alone or associated with low dose of calcineurin inhibitors.
    Perbos E, Juinier E, Guidicelli G, Dromer C, Merville P, Billes MA, Taupin JL, Neau-Cransac M.
    Clin Transplant; 2014 Sep 27; 28(9):1054-60. PubMed ID: 25040585
    [Abstract] [Full Text] [Related]

  • 10. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
    Huang Y, Ramon D, Luan FL, Sung R, Samaniego M.
    Clin Transpl; 2012 Sep 27; ():247-56. PubMed ID: 23721029
    [Abstract] [Full Text] [Related]

  • 11. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
    Wozniak LJ, Hickey MJ, Venick RS, Vargas JH, Farmer DG, Busuttil RW, McDiarmid SV, Reed EF.
    Transplantation; 2015 Jul 27; 99(7):1416-22. PubMed ID: 26038872
    [Abstract] [Full Text] [Related]

  • 12. Crossmatch-positive liver transplantation in patients receiving thymoglobulin-rituximab induction.
    Kubal CA, Mangus RS, Saxena R, Lobashevsky A, Higgins N, Agarwal A, Fridell JA, Tector AJ.
    Transplantation; 2014 Jan 15; 97(1):56-63. PubMed ID: 24030603
    [Abstract] [Full Text] [Related]

  • 13. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
    Almeshari K, Pall A, Chaballout A, Elgamal H, Almana H, Alzayer F, Abaalkhail N, Altalhi M.
    Clin Transpl; 2011 Jan 15; ():395-400. PubMed ID: 22755437
    [Abstract] [Full Text] [Related]

  • 14. Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation.
    Kanter Berga J, Pallardo Mateu LM, Beltran Catalan S, Puig Alcaraz N, Sancho Calabuig A, Gavela Martinez E, Avila Bernabeu A, Crespo Albiach J.
    Transplant Proc; 2011 Jan 15; 43(6):2154-6. PubMed ID: 21839219
    [Abstract] [Full Text] [Related]

  • 15. Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure.
    Iacob S, Cicinnati VR, Lindemann M, Heinemann FM, Radtke A, Kaiser GM, Kabar I, Schmidt HH, Baba HA, Beckebaum S.
    Transplantation; 2015 Sep 15; 99(9):1869-75. PubMed ID: 25706274
    [Abstract] [Full Text] [Related]

  • 16. Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation.
    Grabhorn E, Binder TM, Obrecht D, Brinkert F, Lehnhardt A, Herden U, Peine S, Nashan B, Ganschow R, Briem-Richter A.
    Transplantation; 2015 Sep 15; 99(9):1876-81. PubMed ID: 25706279
    [Abstract] [Full Text] [Related]

  • 17. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C.
    Transplantation; 2009 May 27; 87(10):1505-13. PubMed ID: 19461487
    [Abstract] [Full Text] [Related]

  • 18. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
    Ashimine S, Watarai Y, Yamamoto T, Hiramitsu T, Tsujita M, Nanmoku K, Goto N, Takeda A, Katayama A, Uchida K, Kobayashi T.
    Kidney Int; 2014 Feb 27; 85(2):425-30. PubMed ID: 23945498
    [Abstract] [Full Text] [Related]

  • 19. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
    Perera MT, Silva MA, Murphy N, Briggs D, Mirza DF, Neil DA.
    Scand J Gastroenterol; 2013 Dec 27; 48(12):1444-51. PubMed ID: 24131305
    [Abstract] [Full Text] [Related]

  • 20. Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations.
    Dieplinger G, Ditt V, Arns W, Huppertz A, Kisner T, Hellmich M, Bauerfeind U, Stippel DL.
    Transpl Int; 2014 Jan 27; 27(1):60-8. PubMed ID: 24131087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.